CD8A and neoplasm: Radiotherapy can promote CD8+ T cell responses to radiotherapy-induced peptides (51), natural (52, 53) or exogenous tumor antigens (54, 55), or by promoting immune control within the tumor-microenvironment (51, 56–58) [reviewed in Ref.